New developments in wound healing relevant to facial plastic surgery.
To review new advances in wound healing over the last decade relevant to facial plastic surgery, recent studies in wound healing and its clinical implications were evaluated. New biological and clinical products in wound healing have implications in facial plastic surgery. These products will alter the method with which we approach normal and poorly healing wounds. The US Food and Drug Administration approval of growth factor products signifies the beginning of a new age for actively promoting the healing of wounds for the surgeon. Some of these recent discoveries in wound healing relevant to the facial plastic surgeon are described.
Hom
David B
DB
Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, PO Box 670528, 231 Albert Sabin Way, Cincinnati, OH 45267-0528, USA. david.hom@uc.edu
D002921:Cicatrix / Q000517:prevention & control; D004954:Esthetics; D005145:Face / Q000601:surgery*; D005151:Facial Injuries / Q000175:diagnosis / Q000601:surgery; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use*; D005544:Forecasting; D005782:Gels; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009779:Occlusive Dressings; D011379:Prognosis; D012038:Regeneration; D015361:Rhytidoplasty / Q000592:standards / Q000639:trends; D018570:Risk Assessment; D017768:Skin, Artificial; D013518:Surgery, Plastic / Q000379:methods* / Q000639:trends; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology
D015718:Fibrin Tissue Adhesive; D005782:Gels; D006133:Growth Substances